BioSapien Secures $5.5M in Pre-Series A Funding for Innovative Drug Delivery Platform
BioSapien, a pioneering drug delivery platform focused on localized cancer treatment, has announced the successful closure of a $5.5 million (AED 20.2 million) pre-Series A funding round. The round was led by Global Ventures, with participation from Dara Holdings. Fueling…